FUJIFILM Biotechnologies Capabilities Update August 2026: CPHI Special Edition

As demand for global biologics manufacturing continues to grow, developers are seeking greater flexibility, speed and supply resilience. Join George Sakellariou, Vice President, Global Account Management to learn how FUJIFILM Biotechnologies’ recent investments across its global CDMO network are helping customers accelerate development, reduce risk, and support commercial success.

Key points include:

• Process development and mid-scale manufacturing solutions that enable flexibility and supply security
• Large-scale global drug substance manufacturing capabilities
• Recent investments and expanded capabilities in Hillerød, Denmark
• Holly Springs selection in FDA PreCheck Pilot Program

Visit the FUJIFILM Biotechnologies team at CPHI to continue the conversation and learn more about our global manufacturing capabilities.